Xencor
(NASDAQ:XNCR)
$30.11
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$30.11
After Hours: 4:02PM EDT
Day Range- - -52 Wk Range19.36 - 42.3Open / Close- / -Float / Outstanding36.2M / 59.9M
Vol / Avg.- / 336.9KMkt Cap1.8BP/E61.4550d Avg. Price27.79
Div / Yield-Payout Ratio-Total Float36.2MEPS-0.55

Xencor Stock (NASDAQ:XNCR), Quotes and News Summary

Xencor Stock (NASDAQ: XNCR) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range19.36 - 42.3Open / Close- / -Float / Outstanding36.2M / 59.9M
Vol / Avg.- / 336.9KMkt Cap1.8BP/E61.4550d Avg. Price27.79
Div / Yield-Payout Ratio-Total Float36.2MEPS-0.55
Business Wire - Nov 10, 2022, 4:01PM
Business Wire - Nov 7, 2022, 4:01PM
Business Wire - Aug 3, 2022, 4:01PM
Business Wire - May 5, 2022, 4:01PM
Business Wire - Feb 2, 2022, 4:01PM
TipRanks - Nov 13, 2022, 10:57PM
Seeking Alpha - Nov 7, 2022, 11:36PM
InvestorsObserver - Oct 13, 2022, 6:57AM
InvestorsObserver - Sep 22, 2022, 3:05PM
TipRanks - Aug 4, 2022, 11:19PM
InvestorsObserver - Aug 4, 2022, 1:14PM
Seeking Alpha - Aug 4, 2022, 9:11AM
Seeking Alpha - Jul 6, 2022, 2:57PM
InvestorPlace - May 13, 2022, 9:18AM
Sector: Health Care.Industry: Biotechnology
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-22
REV
Q3 2022Est.ActualSurprise
EPS-0.680-0.550 0.1300
REV20.960M27.299M6.339M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Xencor (XNCR) stock?

A

You can purchase shares of Xencor (NASDAQ: XNCR) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Xencor (XNCR) stock?

A

The latest price target for Xencor (NASDAQ: XNCR) was reported by RBC Capital on Tuesday, November 8, 2022. The analyst firm set a price target for 36.00 expecting XNCR to rise to within 12 months (a possible 19.56% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Xencor (XNCR)?

A

The stock price for Xencor (NASDAQ: XNCR) is $30.11 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Xencor (XNCR) pay a dividend?

A

There are no upcoming dividends for Xencor.

Q

When is Xencor (NASDAQ:XNCR) reporting earnings?

A

Xencor’s Q4 earnings are confirmed for Wednesday, February 22, 2023.

Q

Is Xencor (XNCR) going to split?

A

There is no upcoming split for Xencor.

Q

What sector and industry does Xencor (XNCR) operate in?

A

Xencor is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.